MENU
+Compare
CTXR
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.80
Change
-$0.05 (-2.70%)
Capitalization
15.47M

CTXR Citius Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

a pharmaceutical company

Industry Biotechnology
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CTXR with price predictions
Feb 21, 2025

CTXR in -16.28% downward trend, falling for three consecutive days on February 21, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CTXR declined for three days, in of 301 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CTXR as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CTXR turned negative on February 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for CTXR entered a downward trend on February 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTXR advanced for three days, in of 237 cases, the price rose further within the following month. The odds of a continued upward trend are .

CTXR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.236) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). CTXR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.218).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CTXR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTXR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CTXR is expected to report earnings to fall 16.67% to -5 cents per share on November 27

Citius Pharmaceuticals Inc CTXR Stock Earnings Reports
Q3'24
Est.
$-0.05
Q2'24
Missed
by $0.01
Q1'24
Est.
$-0.05
Q4'23
Missed
by $0.19
Q3'23
Missed
by $0.03
The last earnings report on August 13 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 130.43K shares outstanding, the current market capitalization sits at 15.47M.
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
11 Commerce Drive
Phone
+1 908 967-6677
Employees
22
Web
https://www.citiuspharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLL5.33-0.03
-0.56%
Full House Resorts
VRME0.94-0.02
-1.73%
VerifyMe
JBL162.61-3.51
-2.11%
Jabil
CTRE24.93-0.69
-2.69%
CareTrust REIT
KRUS69.85-4.19
-5.66%
Kura Sushi USA

CTXR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with EYEN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then EYEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
-2.70%
EYEN - CTXR
47%
Loosely correlated
-2.89%
ALEC - CTXR
31%
Poorly correlated
+0.54%
VERA - CTXR
28%
Poorly correlated
-3.48%
ZURA - CTXR
27%
Poorly correlated
-2.78%
PBYI - CTXR
27%
Poorly correlated
-0.51%
More